

Heparin(Heparin Sodium and Heparin Calcium)
Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The global Heparin market research reports indicate a steady growth rate due to increasing demand for anticoagulants in various medical applications.
Heparin Sodium and Heparin Calcium are the dominant forms in the market. The market size is projected to reach $X billion by 2025, driven by rising incidences of cardiovascular diseases and surgeries.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Hepalink
◍ Changshan Pharm
◍ Qianhong Bio-pharma
◍ Opocrin
◍ Pfizer
◍ Aspen (N.V.Organon)
The competitive landscape of the Heparin Market is dominated by companies such as Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen, King-friend Biochemical Pharmaceutical, Bioibérica, Dongcheng Biochemicals, Jiulong Biochemicals, Tiandong, Xinbai, Yino Pharma Limited, and Deebio. These companies contribute to market growth through product innovation, strategic partnerships, and geographic expansion.
- Hepalink: $1.2 billion
◍ King-friend Biochemical Pharmaceutical
◍ Bioibérica
◍ Dongcheng Biochemicals
◍ Jiulong Biochemicals
◍ Tiandong
◍ Xinbai
◍ Yino Pharma Limited
◍ Deebio
- Qianhong Bio-pharma: $780 million
- Pfizer: $2.5 billion Request Sample
◍ Unfractionated Heparin
◍ Low Molecular Heparin API
◍ Heparin Sodium
◍ Heparin Calcium
Request Sample Report